News for 'drug money'

WHO drops Cipla: HIV drug list

WHO drops Cipla: HIV drug list

Rediff.com16 Jun 2004

The World Health Organisation has excluded two generic antiretroviral drugs of Cipla from its list of approved HIV medicines used more often in poor countries.

Norms: US drug regulator warns Sun Pharma

Norms: US drug regulator warns Sun Pharma

Rediff.com1 Sep 2010

The United States Food and Drug Administration has issued a warning letter to it for manufacturing practice violations at its Cranbury facility in New Jersey.

MNCs' diabetes drug patents worry experts

MNCs' diabetes drug patents worry experts

Rediff.com28 Feb 2008

Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the country.

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

Sun Pharma gets USFDA nod for epilepsy drug

Sun Pharma gets USFDA nod for epilepsy drug

Rediff.com17 Jun 2010

Drug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Wockhardt receives US nod for cardiac drug

Wockhardt receives US nod for cardiac drug

Rediff.com23 Jul 2010

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

India could be 'efficacy test' for TB drug okayed by US

India could be 'efficacy test' for TB drug okayed by US

Rediff.com17 Mar 2013

There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.

Court allows Cipla to market disputed drug

Court allows Cipla to market disputed drug

Rediff.com20 Mar 2008

The interim order was passed by the court on Wednesday on a plea filed by Roche Scientific on January 19 this year. The generic name of the drug is Erlotnib, which Roche markets as Tarceva and Cipla as Erlocip. Ahead of the next hearing, the court has asked Cipla to maintain records of sales of Erlocip.

How free drug policy will redefine health insurance

How free drug policy will redefine health insurance

Rediff.com17 Jul 2012

Insurers may be burning their fingers in urban health portfolios for some time now, but the government's rural healthcare initiatives, including its decision to provide free generic drugs to public hospitals, are set to offer fresh avenues of growth for them.

Safin to Agassi: Give back titles and prize money

Safin to Agassi: Give back titles and prize money

Rediff.com10 Nov 2009

Marat Safin has come up with an instant remedy to help Andre Agassi clear his conscience after his admission that he lied about using drugs - hand back the millions of dollars he made in prize money.

'We are waiting for you': Messi gets death threats

'We are waiting for you': Messi gets death threats

Rediff.com5 Mar 2023

The message of support from Newell's was posted on social media hours before Saturday's home game against Barracas Central in the Argentine league.

SRK pays just tribute to Big B's Don

SRK pays just tribute to Big B's Don

Rediff.com20 Oct 2006

Aryan Khan was framed for Rs 18 crore, claims another witness

Aryan Khan was framed for Rs 18 crore, claims another witness

Rediff.com7 Nov 2021

Vijay Pagare, who claims to be an eyewitness in the ongoing drugs on cruise case, alleged that Bollywood superstar Shah Rukh Khan's son Aryan Khan was framed deliberately by some people to make money.

All essential drugs may come under price control

All essential drugs may come under price control

Rediff.com15 Jul 2010

The Union ministry of chemicals and fertilisers has initiated a move to bring all essential medicines sold in the country under a price cap.

Paswan promises to cut drug prices

Paswan promises to cut drug prices

Rediff.com21 Jun 2004

Union Minister for Chemicals and Fertilisers Ram Vilas Paswan said on Monday that his ministry would cut the prices of life saving and other important drugs by bringing more drugs under the 'price monitoring system' and also check the manufacture and

Ranbaxy resumes drug exports to US after 4 years

Ranbaxy resumes drug exports to US after 4 years

Rediff.com2 Apr 2012

The firm, however, said the anti-cholesterol tablets meant for the US market will be produced at its Mohali SEZ plant in Punjab and not at the three units banned by the US health regulator.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Messiah of the masses: Cipla's global crusade for low cost drugs

Messiah of the masses: Cipla's global crusade for low cost drugs

Rediff.com24 Dec 2014

Drug maker Cipla always fought a lone battle to make drugs affordable in India.

Patent office rejects Roche claim on eye drug

Patent office rejects Roche claim on eye drug

Rediff.com6 May 2010

Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

Regulator revises prices of 130 drugs

Regulator revises prices of 130 drugs

Rediff.com3 Aug 2007

In a decision that would impact the entire pharmaceutical industry, the National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of 130 common drugs and antibiotics.

Nicholas Piramal develops drug leads from Antarcti

Nicholas Piramal develops drug leads from Antarcti

Rediff.com29 Jun 2007

Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.

'Price control hinders fight against fake drugs'

'Price control hinders fight against fake drugs'

Rediff.com21 Aug 2007

Price control of drugs in India is making it difficult for companies to fight against spurious medicines as they are unable to set off the resultant increase in cost, Nicolas Piramal director Swati Piramal said on Tuesday.

Beware! 12% drugs are substandard

Beware! 12% drugs are substandard

Rediff.com26 Sep 2003

Around 12 per cent of the drugs sold in the open market across the country are "sub-standard" and over 0.5 per cent are "spurious," a senior official of Union health ministry said in Lucknow.

Nawab Malik exposed farce behind Aryan case: Raut

Nawab Malik exposed farce behind Aryan case: Raut

Rediff.com28 May 2022

Talking to reporters in Kolhapur, Raut said Malik is paying the price for exposing the farce behind the case and the real face of the BJP.

Dr Reddy's plans to brand US speciality drugs

Dr Reddy's plans to brand US speciality drugs

Rediff.com25 Aug 2008

Dr Reddy's Laboratories plans to brand its speciality drugs sold in the US. It will begin selling branded skin care products by year-end. The venture will be spearheaded by Promius Pharma, a wholly owned subsidiary of its US arm

Cymbiotics, Elder Pharma sign 3 drug deal

Cymbiotics, Elder Pharma sign 3 drug deal

Rediff.com29 May 2007

Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.

Essential drugs go missing from counter on low margins

Essential drugs go missing from counter on low margins

Rediff.com4 Sep 2013

Medicines, including antibiotics, contraceptives and anti-diabetic drugs, were found to be out of stock at various places around Delhi.

Ranbaxy shares jump on drug approval in US

Ranbaxy shares jump on drug approval in US

Rediff.com27 Jun 2014

Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share deal.

India battles HIV/AIDS drug shortage as some firms halt supply

India battles HIV/AIDS drug shortage as some firms halt supply

Rediff.com4 Sep 2014

India had the third-largest number of people living with HIV in the world at the end of 2013 and accounts for about four out of 10 people living with HIV in the Asian region.

Will India's Covaxin be world's first COVID-19 drug?

Will India's Covaxin be world's first COVID-19 drug?

Rediff.com3 Jul 2020

'We need to prove to the world that quality vaccines and R&D are possible in India.'

Ranbaxy gets Canada nod to market cholesterol drug

Ranbaxy gets Canada nod to market cholesterol drug

Rediff.com21 Jul 2009

The company's Canadian subsidiary Ranbaxy Pharmaceuticals -- Canada Inc has received final approval from TPD to manufacture and market Ran-Simvastatin tablets, the Gurgaon-headquartered pharma major said in a statement. The approval for Ran-Simvastatin tablets, which are used as a lipid metabolism regulator, is in the strength of 5, 10, 20, 40 and 80 mg.

Our current drugs in India, global markets safe: Ranbaxy

Our current drugs in India, global markets safe: Ranbaxy

Rediff.com31 May 2013

The company's move follows reports of a circular by Mumbai's Jaslok Hospital, that put restrictions on prescribing Ranbaxy Laboratories products.

Govt to reduce cancer drug prices soon

Govt to reduce cancer drug prices soon

Rediff.com3 Dec 2009

Replying to supplementaries during Question Hour in the Lok Sabha, minister of state for chemicals and fertilisers Srikant Jena said the National Pharmaceutical Pricing Authority has been asked to look into demands for bringing 23 anti-cancer drugs within the ambit of price control.